Expanding diagnostics footprint in East India
Patna, India | June 15, 2022: Global pharma major Lupin Limited (Lupin) announced today that Lupin Diagnostics has launched its first Regional Reference Laboratory in Patna, Bihar.
The new Regional Reference Laboratory at Patna has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytology, microbiology, serology, haematology, immunology and routine biochemistry.
By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar. Earlier this year, Lupin Diagnostics opened its Regional Reference Laboratories in Assam and West Bengal. Through upcoming launches of laboratories in Jharkhand (Ranchi) and Orissa (Bhubaneshwar), the company is poised to solidify its position in East India. Lupin Diagnostics now operates through more than 100 diagnostic centers in East India and close to 280 centers across the country.
Ravindra Kumar, Vice President and Head – Lupin Diagnostics said, “We are pleased to announce the launch of our Regional Reference Laboratory in Patna. Through this we plan to provide quality and affordable testing services for a broad range of routine and specialized tests across the state of Bihar. By leveraging our extensive network of LupiMitra centers, we will make quality diagnostics services available to patients even in the most remote areas.”
Lupin Diagnostics offers a comprehensive range of diagnostics services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled temperature–controlled sample movement, smart reports, free home collection, NABL accreditation of each laboratory, trend report analysis, and live home collection booking and tracking. The company started its journey by establishing a state-of-the-art 45,000 square foot National Reference Laboratory in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists, and stringent quality control protocols.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
The Company enjoys a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions. The company invested 8.7% of its revenue in research and development in FY22.
Lupin has 15 manufacturing sites, 7 research centres, more than 20,000 professionals working globally, and has been consistently recognized as a ‘Great Place to Work’ in the Biotechnology & Pharmaceuticals sector.
Please visit www.lupin.com for more information.
About Lupin Diagnostics
Lupin Diagnostics is a part of Lupin Healthcare Limited, which is a wholly owned subsidiary of Lupin Limited. Founded in October 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients, and consumers.
The company began its journey by establishing a state- of-the-art 45,000 sq. ft. National Reference Laboratory located in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols. Over 2500 tests including routine and high-end tests are offered under Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, immunology, and routine biochemistry).
Currently, the company’s network consists of 18 Labs, close to 280 exclusive collection centers (LupiMitra), and over 450 pick-up points.
Experience the best diagnostic experiences with Lupin Diagnostics-https://www.lupindiagnostics.com/
Follow us on Facebook: https://www.facebook.com/lupindiagnostics
Twitter: https://twitter.com/LupinDiagnosti1 YouTube:https://www.youtube.com/channel/UCbj3DVAmNdbvZayKc2XCIuA
For further information, please contact –
Vice President & Global Head – Corporate Communications